🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to (1) evaluate the effect of caloric intake o...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-04
Trial ID
NCT01080612
The purpose of this study is to evaluate the amount of GLPG0187 present in ...
Status
Completed
Location
SGS Stuivenberg
Start Date
2012-01
Trial ID
NCT01580644
Treatments Being Tested
Clinical investigation of anti-psoriatic efficacy and atrophy...
Status
Completed
Location
proDERM GmbH
Start Date
2014-03
Trial ID
NCT02111499
Treatments Being Tested
The primary purpose is to demonstrate the bioequivalence of naproxen admini...
Status
Completed
Location
Research Site
Start Date
2011-09
Trial ID
NCT01331993
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, and tolerabi...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT00741884
This study aims to evaluate the efficacy and safety of probiotics for the p...
Status
Recruiting
Location
Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2025-08-07
Trial ID
NCT06892093
Treatments Being Tested
This is a Phase 1, randomized, double-blinded, placebo-controlled, single a...
Status
Completed
Location
CMAX Clinical Research Pty Ltd
Start Date
2025-03-12
Trial ID
NCT06870058
Treatments Being Tested
The Zambia PCPI study will measure the effect of the parasite genotypes ass...
Status
Completed
Location
Nchelenge District
Start Date
2024-07-24
Trial ID
NCT06166498
Treatments Being Tested
The purpose of this study is to assess how well laroprovstat and ezetimibe ...
Status
Active Not Recruiting
Location
Research Site
Start Date
2026-06-10
Trial ID
NCT07622433
This phase I/II trial studies the side effects of panobinostat nanoparticle...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-05-22
Trial ID
NCT03566199
Treatments Being Tested